✅ Model Answer:
• Diagnosis: Acute osteomyelitis of the distal femur — fever (38.8°C), refusal to bear weight, point tenderness over the distal femur (no joint swelling), elevated WBC (14,000), ESR (78), CRP (8.5). X-ray is normal (early stage). MRI (STIR) would show bone marrow edema — the gold standard for diagnosis.
• Any other test: MRI (STIR sequence) for bone marrow edema, blood cultures (positive in 50-70%), bone aspiration for culture (if MRI confirms osteomyelitis and no organism identified), CRP (monitor response).
• What to do next: Start IV antibiotics (empiric: vancomycin + ceftriaxone if MRSA risk; cefazolin if low MRSA). Duration: 3-4 weeks total (switch to oral after clinical improvement, CRP decreasing >50%). Admit for IV antibiotics.
• Follow-up plan: Monitor CRP weekly; should decrease >50% in 7-10 days. If no improvement in 48-72h → repeat MRI for abscess. Consider surgical drainage if abscess. Follow-up for growth disturbance (physeal involvement).

✅ Model Answer:
• Acute osteomyelitis is a bacterial infection of the bone, most commonly affecting the metaphysis of long bones (distal femur, proximal tibia, proximal humerus).
• Pathophysiology: Hematogenous spread (most common) → bacteria lodge in the metaphyseal capillaries (slow blood flow) → inflammation → bone necrosis → abscess formation.
• Age: Most common in children <5 years.
• Common organisms:
- Staphylococcus aureus (most common — 50-70%)
- MRSA (increasingly common)
- Kingella kingae (common in children <4 years)
- Group A Streptococcus (S. pyogenes)
- Streptococcus pneumoniae (rare post-PCV)
- Salmonella (in sickle cell disease)
- Pseudomonas aeruginosa (puncture wounds, immunocompromised)
- Haemophilus influenzae (rare post-Hib vaccination)

✅ Model Answer:
• Classic presentation:
- Fever: High fever (often >38.5°C).
- Point tenderness: Localized tenderness over the affected bone (most specific sign).
- Refusal to bear weight: On the affected limb.
- Swelling and erythema: May be present (but can be absent early).
- Limited range of motion: Due to pain.
- No joint effusion: (differentiates from septic arthritis).
- History of trauma: May be absent.
• Common sites:
- Distal femur (most common)
- Proximal tibia
- Proximal humerus
- Distal radius
- Pelvis (less common)
- Vertebrae (discitis)
• Systemic symptoms: Malaise, irritability, poor feeding.

✅ Model Answer:
• X-ray: Normal in the first 7-14 days (bone changes take 7-10 days to appear). Findings: soft tissue swelling, periosteal reaction, lytic lesions (late).
• MRI (with STIR sequence): The gold standard — shows bone marrow edema (hypointense on T1, hyperintense on STIR). Sensitivity 95-100%. Also detects abscesses, subperiosteal collections, and joint involvement.
• CT: Less sensitive than MRI; used for surgical planning (if abscess).
• Ultrasound: Can detect subperiosteal abscess (if present).
• Bone scan (technetium-99m): Used if MRI is not available; shows increased uptake in affected bone.
• PET-CT: Rarely used in children.

✅ Model Answer:
• IV antibiotics:
- Empiric: Vancomycin + ceftriaxone (if MRSA risk) OR cefazolin (if low MRSA risk).
- Duration: IV antibiotics for 3-4 weeks total (or until CRP normalizes).
- Switch to oral: When clinical improvement, CRP decreased >50%, and organism susceptibility is known.
- Oral step-down: Cephalexin, clindamycin, or TMP-SMX (based on sensitivities).
• Monitoring: CRP (should decrease >50% in 7-10 days).
• Surgical intervention:
- Indications: Abscess formation, failure to improve in 48-72 hours, or if the organism is MRSA.
- Procedure: Drainage of abscess, debridement of necrotic bone.
• Supportive care: Pain management, hydration, immobilization (if needed).
• Follow-up: Clinical improvement within 48-72 hours.

✅ Model Answer:
• CRP (C-reactive protein): An acute-phase reactant that rises rapidly (within 6-12 hours) and falls quickly with effective treatment.
• Monitoring:
- Baseline: Elevated (often >5-10 mg/dL).
- Response: Should decrease by >50% within 7-10 days of starting antibiotics.
- If not decreasing: Consider inadequate treatment, abscess formation, or resistant organism.
- Normalization: Usually by 2-4 weeks (but can take longer).
• ESR: Falls more slowly than CRP (may take weeks to normalize).
• Clinical use: CRP is the best marker for monitoring treatment response. If CRP fails to decrease, repeat MRI for abscess.

✅ Model Answer:
• Complications:
- Chronic osteomyelitis: If inadequately treated (persistent infection, bone necrosis, sinus tract formation).
- Septic arthritis: If infection spreads from the metaphysis into the joint (especially in neonates with intra-articular metaphysis).
- Abscess formation: Subperiosteal or intramedullary abscess.
- Growth disturbance: If the physis (growth plate) is involved → leg length discrepancy, angular deformity.
- Pathologic fracture: Weakening of the bone.
- Septicemia: Bacteremia, sepsis.
- Death: Rare, but possible in severe cases (sepsis).
- Avascular necrosis: If vascular supply is compromised.

✅ Model Answer:
• Prognosis:
- Excellent: With prompt diagnosis and appropriate IV antibiotics (95% cure rate).
- Good: If treated within 48-72 hours of symptom onset.
- Guarded: If diagnosis is delayed, if there is abscess formation, or if MRSA is the causative organism.
- Complications: Higher risk of growth disturbance and chronic osteomyelitis if treatment is delayed.
- Mortality: <1% in developed countries.
• Long-term follow-up:
- Monitor growth: Clinical assessment for leg length discrepancy, angular deformity (especially if the physis is involved).
- Follow-up X-rays: At 6-12 weeks to assess bone healing and rule out growth disturbance.
- Physical therapy: If joint stiffness or muscle atrophy occurs.
- Repeat MRI: If symptoms recur or if healing is not progressing.
- Orthopedic follow-up: For 1-2 years to monitor for complications.